Navigation Links
Rutgers scholar authors definitive biography of reproductive medicine pioneer
Date:10/17/2008

CAMDEN As Louise Brown the first baby conceived by in vitro fertilization celebrates her 30th birthday in 2008, a new book coauthored by a Rutgers medical historian offers the first comprehensive insight into the influence of John Rock, the Harvard-affiliated gynecologist and pioneering researcher, in shaping the field of modern reproductive medicine.

Rock was the first researcher to fertilize a human egg in vitro in the 1940s and the co-developer of the first oral contraceptive a decade later. His groundbreaking studies of the human embryo, tracing the path from ovulation to implantation in the uterus, provided the first visual record of the earliest stages of pregnancy.

A new book by Margaret Marsh, distinguished professor of history and interim chancellor at Rutgers UniversityCamden, and her sister, Wanda Ronner, a clinical associate professor of obstetrics and gynecology at the University of Pennsylvania School of Medicine, closely examines Rock's 50-year career. His work defined the reproductive revolution, with its twin symbols of the birth control pill and technologically assisted reproduction.

Their collaboration, "The Fertility Doctor: John Rock and the Reproductive Revolution" (John Hopkins University Press, 2008), is the first full-scale historical biography of Rock, who began his working life as a time-keeper on a banana plantation in Guatemala, later became the nation's leading figure in the treatment of infertility, and ended his career as perhaps the world's most recognized advocate for the birth control pill.

"He was the leading clinician in the field of reproductive medicine before the field even had a name," Marsh explains. "We were fascinated by him. We thought he deserved a serious biography."

The authors found Rock's personal story compelling as well. In the 1930s, he was the only Catholic doctor in Massachusetts to support the repeal of a Massachusetts law that prohibited the use of birth control even by married couples. In the 1950s, he joined forces with biologist Gregory Pincus to develop the first oral contraceptive.

Marsh and Ronner were the first scholars to examine Rock's personal family papers, which included diaries, patient records, and correspondence with men and women from all walks of life around the nation and throughout the world. Rock's daughter, Rachel Achenbach, granted them unrestricted access to these documents.

"What I found so interesting about him was his willingness to try to find answers to medical questions that at the time, were so out of his reach,'' Ronner says. "He was doing experiments in his office. And he would do things like inject himself with the solvents that drug companies were using for treatments such as injectable progesterone, and report back on whether he'd had a reaction.''

As director of the Harvard-affiliated Fertility and Endocrine Clinic at the Free Hospital for Women in Boston, Rock treated women from all walks of life, from film stars to at least one African princess, to the wives of elevator operators and laborers. He stands out, the authors say, for his ability to communicate with patients.

"He was absolutely in partnership with his patients. He always discussed their conditions and treatment options with them, and he trusted their intelligence and decision-making ability," Marsh says. "He was ahead of his time in seeking informed consent."

Some of Rock's research ignited controversy in the 1970s and 1980s, when Christian conservatives insisted that his earlier embryo experiments were unethical and some feminists argued that he had misled the patients who participated in them.

The Rock biography grew out of an earlier collaboration between Marsh and Ronner on the book, "The Empty Cradle: Infertility in America from Colonial Times to the Present" (Johns Hopkins, 1996).


'/>"/>

Contact: Mike Sepanic
msepanic@camden.rutgers.edu
856-225-6026
Rutgers University
Source:Eurekalert

Related biology news :

1. Rutgers Genetics receives $7.8 million for autism research
2. Rutgers high school outreach gets $3 million boost from NSF
3. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
4. Rutgers scientists research reveals critical knowledge about the nervous system
5. USDA Cooperative Agreement funds mosquito project at Rutgers
6. Raydiance collaborates with Rutgers, MTF to develop innovative tissue processing approaches
7. Better protection for biomedial devices could result from Rutgers-Camden research
8. Rutgers biologist to study worms in Amazon, glaciers
9. $3.2M for Rutgers to apply biology, engineering, physical sciences toward stem cells
10. No helicopter moms among Rutgers mutant mice
11. UM coral scientist Peter Glynn wins award for scholarly activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2017)... HANOVER, Germany , March 16, 2017 CeBIT 2017 - Against ... Continue Reading ... Used combined in one project, multi-biometric solutions ... ... Identification Systems) ...
(Date:3/7/2017)... -- Brandwatch , the leading social intelligence company, today announces ... to uncover insights to support its reporting, help direct future campaigns, ... leading youth charity will be using Brandwatch Analytics social listening and ... understanding of the topics and issues that are a priority for ... "Until ...
(Date:3/2/2017)... -- Summary This report provides all the ... its partnering interests and activities since 2010. Download ... Partnering Deals and Alliance since 2010 report provides an ... the world,s leading life sciences companies. On ... inclusion of the most up to date deal and ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... MA (PRWEB) , ... March 23, 2017 , ... ... “a viscoelastic material that exhibits both viscous and elastic characteristics when deformed, which ... disc polymer exhibits properties to gently absorb compressive forces and return to its ...
(Date:3/23/2017)... -- GlobeImmune, Inc. today announced it has entered into a ... of its common stock to NantCell, Inc., a member ... sale of its common stock, NantCell has agreed to ... 200,000 shares, an estimated $2.0 million in value, of ... to enter into this strategic agreement with NantCell," said ...
(Date:3/23/2017)... According to a report by Transparency Market Research (TMR), ... the presence of a large pool of participants; however, only a ... Sigma-Aldrich, compete with each other in this market. With Proliant being ... of this market in 2016.  ... As of now, a large number of vendors are ...
(Date:3/22/2017)... Mass. (PRWEB) , ... March 22, 2017 , ... ... scale up human tissue regeneration from small lab samples to full-size tissues, bones, ... how to establish a vascular system that delivers blood deep into the developing ...
Breaking Biology Technology: